Diagnostic criteria for respiratory chain disorders in adults and children.
BACKGROUND
Respiratory chain (RC) disorders are clinically, biochemically, and molecularly heterogeneous. The lack of standardized diagnostic criteria poses difficulties in evaluating diagnostic methodologies.


OBJECTIVE
To assess proposed adult RC diagnostic criteria that classify patients into "definite," "probable," or "possible" categories.


METHODS
The authors applied the adult RC diagnostic criteria retrospectively to 146 consecutive children referred for investigation of a suspected RC disorder. Data were collected from hospital, genetics, and laboratory records, and the diagnoses predicted by the adult criteria were compared with the previously assigned assessments.


RESULTS
The authors identified three major difficulties in applying the adult criteria:lack of pediatric-specific criteria; difficulty in segregating continuous data into circumscribed major and minor criteria; and lack of additivity of clinical features or enzyme tests. They therefore modified the adult criteria to allow for pediatric clinical and histologic features and for more sensitive coding of RC enzyme and functional studies. Reanalysis of the patients' data resulted in congruence between the diagnostic certainty previously assigned by the authors' center and that defined by the new general RC diagnostic criteria in 99% of patients.


CONCLUSIONS
These general diagnostic criteria appear to improve the sensitivity of the adult criteria. They need further assessment in prospective clinical and epidemiologic studies.
Bernier
F P
FP
Murdoch Childrens Research Institute, Royal Children's Hospital, Flemington Road, Parkville VIC 3052, Australia.
Boneh
A
A
Dennett
X
X
Chow
C W
CW
Cleary
M A
MA
Thorburn
D R
DR
D000328:Adult; D001706:Biopsy; D002478:Cells, Cultured; D002648:Child; D004272:DNA, Mitochondrial / Q000235:genetics; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D004579:Electron Transport; D005347:Fibroblasts / Q000166:cytology; D006801:Humans; D007888:Leigh Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D017241:MELAS Syndrome / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D028361:Mitochondrial Diseases / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D018485:Muscle Fibers, Skeletal / Q000201:enzymology / Q000473:pathology; D018482:Muscle, Skeletal / Q000378:metabolism / Q000473:pathology; D009154:Mutation; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D012680:Sensitivity and Specificity
D004272:DNA, Mitochondrial; D011451:Prostaglandin-Endoperoxide Synthases